ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,246, issued on Dec. 9, was assigned to Neuracle Science Co. Ltd. (Seoul, South Korea).
"Anti-FAM19A5 antibodies and uses thereof" was invented by Bongcheol Kim (Seongnam-si, South Korea), Jae-Keun Lee (Seoul, South Korea), Dong Sik Kim (Seoul, South Korea), Junho Chung (Seongnam-si, South Korea) and Junyeong Jin (Gwachun-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies that specifically bind to human FAM19A5 and compositions comprising such antibodies. Also provided herein are methods for treating fibrosis or cancer using the anti-FAM19A5 antibodies."
The patent was filed on March 2, 2023, und...